Population pharmacokinetics of halofantrine in healthy volunteers and patients with symptomatic falciparum malaria
Aims To investigate the population pharmacokinetics of the antimalarial halofantrine (HF) in healthy volunteers and patients with symptomatic falciparum malaria. Methods Healthy volunteer data were obtained from six volunteers who received three different doses of HF (250, 500 and 1000 mg) after an...
Hoofdauteurs: | Klein, K, Aarons, L, Ter Kuile, F, Nosten, F, White, N, Edstein, MD, Teja-Isavadharm, P |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
2012
|
Gelijkaardige items
-
Population pharmacokinetics of halofantrine in healthy volunteers and patients with symptomatic falciparum malaria.
door: Klein, K, et al.
Gepubliceerd in: (2012) -
Pharmacokinetics, efficacy and toxicity of parenteral halofantrine in uncomplicated malaria.
door: Krishna, S, et al.
Gepubliceerd in: (1993) -
Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria.
door: ter Kuile, F, et al.
Gepubliceerd in: (1993) -
Comparison of capillary whole blood, venous whole blood, and plasma concentrations of mefloquine, halofantrine, and desbutyl-halofantrine measured by high-performance liquid chromatography.
door: Ter Kuile, F, et al.
Gepubliceerd in: (1994) -
Population pharmacokinetics of mefloquine in patients with acute falciparum malaria.
door: Simpson, J, et al.
Gepubliceerd in: (1999)